TBXT and lung carcinoma: Similarly, the decrease in the MDA level in lung cancer animal model was observed as 21.78% and 43.01% in the presence of PFT-HSA-TFT-Cy7 at 1 μM and 3 μM and 11.73% and 35.75% in the presence of PFT-Hcy-HSA-Cy7 at 1 μM and 3 μM respective to their control.